title: Antisense igf-I for hepatocellular carcinoma.
abstract: Antisense gene therapy involves the selective inhibition of expression or function of disease-causing genes by treatment with an antisense molecules (RNA or oligodeoxynucleotides) complementary to its target nucleic acids, usually to some specific mRNA molecules or mRNA precursor molecules, at a specific site (1,2) (see also Note 1).
authors.affiliation: International Joint Cancer Institute, Second Military Medical University, Shanghai, People's Republic of China.
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.forename: J
authors.initials: J
authors.lastname: Zhao
authors.forename: Y
authors.initials: Y
authors.lastname: Lu
authors.forename: J
authors.initials: J
authors.lastname: Trojan
authors.forename: M
authors.initials: M
authors.lastname: Wu
authors.forename: Y
authors.initials: Y
authors.lastname: Guo